Furthermore, P-RIP3 expression also showed an increasing trend in the NMDA-treated group (1.33±0.05%, n = 3) compared to the control group (1±0, n = 4) ( Figure 4 D).
1
—
—
Furthermore, P-RIP3 expression also showed an increasing trend in the NMDA-treated group (1.33±0.05%, n = 3) compared to the control group (1±0, n = 4) ( Figure 4 D).